These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

453 related items for PubMed ID: 30371109

  • 1. Pediatric Sialorrhea: Submandibular Duct Rerouting and Intraparotid Botulinum Toxin A Injection With Literature Review.
    Calim OF, Hassouna HNH, Yildirim YS, Dogan R, Ozturan O.
    Ann Otol Rhinol Laryngol; 2019 Feb; 128(2):104-112. PubMed ID: 30371109
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effectiveness and safety of botulinum toxin in comparison with surgery for drooling in paediatric patients with neurological disorders: a systematic review.
    Silva JPS, Faria LV, Almeida RC, Medeiros YL, Guimarães LDA.
    Br J Oral Maxillofac Surg; 2022 Jun; 60(5):e691-e701. PubMed ID: 35227530
    [Abstract] [Full Text] [Related]

  • 4. Surgical management of chronic sialorrhea in pediatric patients: 10-year experience from one tertiary care institution.
    Formeister EJ, Dahl JP, Rose AS.
    Int J Pediatr Otorhinolaryngol; 2014 Aug; 78(8):1387-92. PubMed ID: 24974144
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Does the addition of sublingual gland excision to submandibular duct relocation give better overall results in drooling control?
    Glynn F, O'Dwyer TP.
    Clin Otolaryngol; 2007 Apr; 32(2):103-7. PubMed ID: 17403225
    [Abstract] [Full Text] [Related]

  • 7. Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience.
    Mahadevan M, Gruber M, Bilish D, Edwards K, Davies-Payne D, van der Meer G.
    Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():142-5. PubMed ID: 27497402
    [Abstract] [Full Text] [Related]

  • 8. Submandibular duct ligation after botulinum neurotoxin A treatment of drooling in children with cerebral palsy.
    Bekkers S, Pruijn IMJ, Van Hulst K, Delsing CP, Erasmus CE, Scheffer ART, Van Den Hoogen FJA.
    Dev Med Child Neurol; 2020 Jul; 62(7):861-867. PubMed ID: 32149393
    [Abstract] [Full Text] [Related]

  • 9. Submandibular gland botulinum neurotoxin A injection for predicting the outcome of submandibular duct relocation in drooling: a retrospective cohort study.
    Kok SE, van Valenberg HFJP, van Hulst K, Jongerius P, Erasmus CE, van den Hoogen FJA.
    Dev Med Child Neurol; 2019 Nov; 61(11):1323-1328. PubMed ID: 30854648
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparing botulinum toxin and 4-duct ligation for Sialorrhea in children - A systematic review.
    Ha TN, Shih MC, Lambert EM.
    Am J Otolaryngol; 2024 Nov; 45(2):104119. PubMed ID: 38043299
    [Abstract] [Full Text] [Related]

  • 12. Managing children with sialorrhoea (drooling): Experience from the first 301 children in our saliva control clinic.
    Montgomery J, McCusker S, Lang K, Grosse S, Mace A, Lumley R, Kubba H.
    Int J Pediatr Otorhinolaryngol; 2016 Jun; 85():33-9. PubMed ID: 27240493
    [Abstract] [Full Text] [Related]

  • 13. Drooling and Aspiration of Saliva.
    Hughes A, Lambert EM.
    Otolaryngol Clin North Am; 2022 Dec; 55(6):1181-1194. PubMed ID: 36371134
    [Abstract] [Full Text] [Related]

  • 14. Posterior drooling in children with cerebral palsy and other neurodevelopmental disorders.
    Delsing CP, Bekkers S, Erasmus CE, van Hulst K, van den Hoogen FJ.
    Dev Med Child Neurol; 2021 Sep; 63(9):1093-1098. PubMed ID: 33844298
    [Abstract] [Full Text] [Related]

  • 15. The impact of submandibular duct relocation on drooling and the well-being of children with neurodevelopmental disabilities.
    Kok SE, van der Burg JJ, van Hulst K, Erasmus CE, van den Hoogen FJ.
    Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():173-8. PubMed ID: 27497408
    [Abstract] [Full Text] [Related]

  • 16. Treatment of sialorrhea with botulinum toxin A injection in children.
    Ture E, Yazar A, Dundar MA, Bakdik S, Akin F, Pekcan S.
    Niger J Clin Pract; 2021 Jun; 24(6):847-852. PubMed ID: 34121732
    [Abstract] [Full Text] [Related]

  • 17. The impact of botulinum toxin type A in the treatment of drooling in children with cerebral palsy secondary to Congenital Zika Syndrome: an observational study.
    Sales HF, Cerqueira C, Vaz D, Medeiros-Rios D, Armani-Franceschi G, Lucena PH, Sternberg C, Nóbrega AC, Luz C, Fonseca D, Carvalho AL, Monteiro L, Siqueira IC, Bandeira ID, Lucena R.
    Neurol Res; 2021 Jan; 43(1):54-60. PubMed ID: 32915712
    [Abstract] [Full Text] [Related]

  • 18. Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy. Presentation of a case series.
    Jongerius PH, Rotteveel JJ, van den Hoogen F, Joosten F, van Hulst K, Gabreëls FJ.
    Eur J Pediatr; 2001 Aug; 160(8):509-12. PubMed ID: 11548191
    [Abstract] [Full Text] [Related]

  • 19. US-guided botulinum toxin injection for excessive drooling in children.
    Çiftçi T, Akıncı D, Yurttutan N, Akhan O.
    Diagn Interv Radiol; 2013 Aug; 19(1):56-60. PubMed ID: 22798155
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of relocation of submandibular duct in cerebral palsy patients with drooling.
    Puraviappan P, Dass DB, Narayanan P.
    Asian J Surg; 2007 Jul; 30(3):209-15. PubMed ID: 17638641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.